Prothena Corporation Plc Is A Late Stage Clinical Biotechnology Company Based In Dublinirelandwith Research And Development Operations In South San Franciscocaliforniafounded In 2012Prothena Focuses On Developing Therapies For Neurodegenerative And Rare Peripheral Amyloid Diseases By Targeting Misfolded Proteinsthe Company Specializes In Antibody Based Therapeuticsleveraging Its Expertise In Protein Biology And Neuroscience Prothena S Pipeline Includes Investigational Therapies Such As Prasinezumab For Parkinson S Diseasebirtamimab For Al Amyloidosisand Prx012 And Prx005 For Alzheimer S Diseasethe Company Collaborates With Partners Like Bristol Myers Squibb To Advance Its Clinical Programsaiming To Address Unmet Needs In Patient Populations Affected By These Conditionsprothena Is Dedicated To Translating Protein Biology Into Effective Therapiesemphasizing Innovation And Strategic Partnerships In Its Mission
No conferences found for this company.
| Company Name | Prothena Biosciences Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
